|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | HaEmek Medical Center, Israel |
|---|---|
| Information provided by: | HaEmek Medical Center, Israel |
| ClinicalTrials.gov Identifier: | NCT00861523 |
Purpose
There are different treatments for nausea and vomiting in pregnancy. According to the ACOG recommendations, promethazine is the first line of parenteral treatment after oral treatment had failed. Thiamine is given to prevent wernicke encephalopathy. This research try to find out whether thiamine helps the vomiting and nausea as well, by comparing the response to thiamine and promethazine in women who suffer from nausea and vomiting in pregnancy.
| Condition | Intervention | Phase |
|---|---|---|
|
Hyperemesis Gravidarum |
Drug: thiamine & promethazine |
Phase III |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Comparison Between the Treatment of Thiamine and Promethazine for Improving Vomiting and Nausea in Pregnancy |
| Estimated Enrollment: | 280 |
| Study Start Date: | February 2009 |
| Estimated Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1. thiamine
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive thiamine IV
|
Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV
|
|
Active Comparator: 2. promethazine
Pregnant women until 12 week of gestation who refer to the ER because of nausea and vomiting and didn't improve after hydration, will receive promethazine IV
|
Drug: thiamine & promethazine
thiamine 100 mg IV promethazine 25 mg IV
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Yfat Kadan, MD | 972-4-6494331 | yfat_ka@bclalit.org.il; kadana@bezeqint.net |
| Israel | |
| Gynecologic department, Haemek medical center | Recruiting |
| Afula, Israel | |
| Principal Investigator: | Yfat Kadan | Haemek medical center |
More Information
| Responsible Party: | Dep. of OB/GYN, HaEmek Medical Center, yfat kadan |
| ClinicalTrials.gov Identifier: | NCT00861523 History of Changes |
| Other Study ID Numbers: | 0101-08-EMC |
| Study First Received: | February 18, 2009 |
| Last Updated: | May 31, 2010 |
| Health Authority: | israel: helsinky comittee |
|
nausea vomiting pregnancy |
thiamine promethazine nausea and vomiting in pregnancy |
|
Hyperemesis Gravidarum Nausea Vomiting Morning Sickness Pregnancy Complications Signs and Symptoms, Digestive Signs and Symptoms Promethazine Diphenhydramine Thiamine Antipruritics Dermatologic Agents Therapeutic Uses Pharmacologic Actions Histamine H1 Antagonists |
Histamine Antagonists Histamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anti-Allergic Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Central Nervous System Agents Gastrointestinal Agents Hypnotics and Sedatives Central Nervous System Depressants Anesthetics, Local Anesthetics |